As Australia plans its inquiry into the pandemic response, there is still no evidence key recommendations to deploy the National COVID-19 Health Management Plan are in place, six months after its release.
An additional 160,000 Australians are now able to access subsidised COVID-19 antiviral treatments after the federal government expanded eligibility criteria under the Pharmaceutical Benefits Scheme.